Save
esh.org
Panel discussion
ESH eLearning, Faculty / Presenters, 405435
Therapeutic targeting of BCL-2
ESH eLearning, Courtney DiNardo, 405432
Panel discussion
ESH eLearning, Faculty / Presenters, 405431
Germline predisposition to myeloid malignancy
ESH eLearning, Katherine R. CALVO, 405430
Targeted protein degradation for the treatment of hematologic malignancies
ESH eLearning, Benjamin Ebert, 405428
Panel discussion
ESH eLearning, Faculty / Presenters, 405427
AML relapse after allo-HCT: hiding in plain sight
ESH eLearning, John DiPersio, 405426
Targeting of tumor necrosis factor receptors/CD70 in leukemia
ESH eLearning, Adrian Ochsenbein, 405425
Immunotherapeutic targeting of AML and MDS
ESH eLearning, Saar Gill, 405424
The immune landscape of AML and its correlation with immunotherapy outcomes
ESH eLearning, Sergio RUTELLA, 405423
Panel discussion
ESH eLearning, Faculty / Presenters, 405422
Targeting aberrant gene control in AML
ESH eLearning, Alex Kentsis, 405421
Panel discussion
ESH eLearning, Faculty / Presenters, 405418
Where, when and how? Characterising the properties of age-related haematopoietic clones
ESH eLearning, Paresh Vyas, 405416
Interrogating clonal evolution in acute myeloid leukemia
ESH eLearning, Linde Miles, 405415
Panel discussion
ESH eLearning, Faculty / Presenters, 405414
Causes and consequences of clonal haematopoiesis
ESH eLearning, George Vassiliou, 405413
Evolution of clonal haematopoiesis to AML
ESH eLearning, Caroline WATSON, 405412
Linking mutational processes to leukemic development
ESH eLearning, Mathijs Sanders, 405411
Welcome words
ESH eLearning, Faculty / Presenters, 405410
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 405496
Closing Remarks
ESH eLearning, Michael Hallek, 405355
Panel discussion
ESH eLearning, Faculty / Presenters, 405354
Circulating tumor DNA in chronic lymphocytic leukaemia
ESH eLearning, Moritz FÜRSTENAU, 405353
Circulating tumor DNA in primary CNS lymphoma
ESH eLearning, Stefan Alig, 405352
Circulating tumor DNA as predictor for survival in diffuse large B-cell lymphoma
ESH eLearning, Ash Alizadeh, 405351
Panel discussion
ESH eLearning, Faculty / Presenters, 405350
Multi-Targeted Therapy for Diffuse Large B-cell Lymphoma
ESH eLearning, Mark Roschewski, 405349
Timing and duration of targeted therapies, continuous versus MRD-guided versus time-limited?
ESH eLearning, Paolo Ghia, 405348
Venetoclax in combination with other agents in chronic lymphocytic leukaemia and non-Hodgkin lymphoma
ESH eLearning, Michael Hallek, 405347
Panel discussion
ESH eLearning, Faculty / Presenters, 405346
CDK9 inhibitors for double refr. Ibru venetoclax refractory lymphoma/chronic lymphocytic leukaemia
ESH eLearning, Alexey Danilov, 405345
Function and targeting of MALT1 in aggressive lymphomas
ESH eLearning, Daniel Krappmann, 405344
BTK inhibitors in aggressive lymphoma
ESH eLearning, Mark Roschewski, 405343
Panel discussion
ESH eLearning, Faculty / Presenters, 405342
Microenvironmental niche of indolent lymphoma
ESH eLearning, Karin Tarte, 405341
Microenvironment of chronic lymphocytic leukaemia
ESH eLearning, Silvia Deaglio, 405339
Panel discussion
ESH eLearning, Faculty / Presenters, 405338
PI3K inhibitors
ESH eLearning, Georg Lenz, 405337
Tafasitamab CD19 + Len and novel bispecific Ab strategies
ESH eLearning, Gilles SALLES, 405336
Bispecific antibodies in non-Hodgkin lymphoma
ESH eLearning, Martin Hutchings, 405335
Antibody-drug conjugates in relapsed/refractory non-Hodgkin lymphoma
ESH eLearning, Laurie Sehn, 405334
Panel discussion
ESH eLearning, Faculty / Presenters, 405333
“Off-the-shelf” CAR constructs
ESH eLearning, David Miklos, 405332
Novel conceptual design of innovative (CART and NK cell) constructs for lymphoma
ESH eLearning, Catherine Bollard, 405331
CAR T-cells for B-cell lymphoma
ESH eLearning, Jason WESTIN, 405330
Panel discussion
ESH eLearning, Faculty / Presenters, 405329
Landscape and evolution in mantle cell lymphoma
ESH eLearning, Silvia Bea, 405328
Epigenetic dysregulation in diffuse large B-cell lymphoma
ESH eLearning, Ari Melnick, 405327
Mechanisms of B cell lymphomagenesis: Pervasive hypermutation of super-enhancers dysregulates oncogene expression Pervasive hypermutation of super-enhancers dysregulates oncogene expression
ESH eLearning, Riccardo Dalla-Favera, 405326
Panel discussion
ESH eLearning, Faculty / Presenters, 405325
T-cell lymphoma subtypes
ESH eLearning, Javeed Iqbal, 405324
Single cell analytics in lymphoid malignancies - A conceptual overview
ESH eLearning, Catherine Wu, 405322
Panel discussion
ESH eLearning, Faculty / Presenters, 405321
High grade B-cell lymphoma
ESH eLearning, David Scott, 405320
Building lymphoma diffuse large B-cell lymphoma models
ESH eLearning, Daniel HODSON, 405318
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 405495
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 404819
Interactive case: Allo after CAR-T
ESH eLearning, Anna Sureda, 403600
Case-based lecture: Treatment after CAR-T failure in diffuse large B-cell lymphoma: bispecific antibody
ESH eLearning, Elizabeth Budde, 403598
Case-based lecture: CAR-T resistance mechanisms
ESH eLearning, Michael Green, 403597
Interactive case: Relapse in multiple myeloma after CAR-T
ESH eLearning, Lukas Scheller, 403596
Interactive case: CARs and comorbidities
ESH eLearning, Jordan Gauthier, 403595
Case-based lecture: Diffuse large B-cell lymphoma - UK experience
ESH eLearning, Andrea Kuhnl, 403594
Case-based lecture: Diffuse large B-cell lymphoma - US experience
ESH eLearning, Frederick Locke, 403593
Interactive case: Mantle cell lymphoma
ESH eLearning, Gloria Iacoboni, 403592
Pro bispecific antibody
ESH eLearning, Elizabeth Budde, 403591
Pro CAR-T
ESH eLearning, Jeremy Abramson, 403590
Patient’s view of CAR T-cell therapy
ESH eLearning, Jonathan Clark, 403589
Patient perspective
ESH eLearning, Hans Scheurer, 403588
Eligibility and rapid progression
ESH eLearning, Marie José Kersten, 403587
Interactive case: EBMT recommendations
ESH eLearning, Claire Roddie, 403586
Case-based lecture: Cytopenias and infections
ESH eLearning, Kai Rejeski, 403585
Case-based lecture: Immune effector cell associated neurological syndrome: neurotoxicity and long-term symptoms
ESH eLearning, Frederick Locke, 403584
Interactive case: Prediction of toxicity in CARs and bispecifics
ESH eLearning, Anna Sureda, 403582
Access in different ethnic groups
ESH eLearning, Loretta Nastoupil, 403581
Patient survey
ESH eLearning, Natacha Bolanos, 403579
Future projections
ESH eLearning, Frederick Thielen, 403578
Con
ESH eLearning, Jordan Gauthier, 403577
Pro
ESH eLearning, Frederick Locke, 403576
Interactive case: T-cell lymphoma
ESH eLearning, Kate Cwynarski, 403575
Case-based lecture: Follicular lymphoma and T-cell lymphoma
ESH eLearning, Loretta Nastoupil, 403574
Case-based lecture: Mantle cell lymphoma
ESH eLearning, Marie José Kersten, 403573
Case-based Lecture: Adult acute lymphoblastic leukaemia
ESH eLearning, Claire Roddie, 403572
Interactive case: Pediatric acute lymphoblastic leukaemia
ESH eLearning, André Baruchel, 403571
Interactive case: Clinical study opportunities for patients
ESH eLearning, Johannes Waldschmidt, 403570
Case-based lecture: Bispecifics and sequencing in multiple myeloma
ESH eLearning, Monique Minnema, 403569
Case-based lecture: CAR in multiple myeloma
ESH eLearning, María-Victoria Mateos, 403568
Interactive case: CAR-T and infections in multiple myeloma
ESH eLearning, Kai Rejeski, 403567
Interactive case: Follow-up of patients after successful treatment
ESH eLearning, Pere Barba, 403566
Case-based lecture: Alternative cell sources: alloCAR-T, iPSC, NK CAR
ESH eLearning, Stephan Fricke, 403565
Case-based lecture: Bispecific antibodies
ESH eLearning, Martin Hutchings, 403564
Case-based lecture: CAR-T: patient selection and bridging strategies
ESH eLearning, Catherine Thieblemont, 403563
Interactive case: Diffuse large B-cell lymphoma and radiotherapy
ESH eLearning, Tom van Meerten, 403562
CAR T-cell therapy: something old, something new (novel targets/tandem CARs)
ESH eLearning, Jeremy Abramson, 403561
Conference Book (PDF)
ESH eLearning, Faculty / Presenters, 404818
Closing Remarks
ESH eLearning, Jorge Cortes, 404248
Selected Abstract: A predictive scoring system for therapy failure of tyrosine-kinase inhibitors in patients with chronic myeloid leukemia
ESH eLearning, Xiaoshuai ZHANG, 404246
Keynote Presentation: How should we interpret concussions of TKI-stopping studies?
ESH eLearning, Robert Peter GALE, 404245
Hematology service for CML patients in Ukraine: challenges and successes
ESH eLearning, Faculty / Presenters, 404244

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings